Page last updated: 2024-08-17

egtazic acid and kt 362

egtazic acid has been researched along with kt 362 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hester, RK; Satake, N; Shibata, S; Tomiyama, A; Ueda, S; Wakabayashi, S	1

Other Studies

1 other study(ies) available for egtazic acid and kt 362

Article	Year
Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1 Topics: Animals; Caffeine; Calcium Channel Blockers; Diltiazem; Egtazic Acid; Gallopamil; Lanthanum; Male; Methoxamine; Muscle Contraction; Nifedipine; Nitroglycerin; Norepinephrine; Rabbits; Thiazepines; Vasodilation; Verapamil	1987

Article

Year

Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist.

The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1

Topics: Animals; Caffeine; Calcium Channel Blockers; Diltiazem; Egtazic Acid; Gallopamil; Lanthanum; Male; Methoxamine; Muscle Contraction; Nifedipine; Nitroglycerin; Norepinephrine; Rabbits; Thiazepines; Vasodilation; Verapamil

1987